Chief Commercial Officer · Acorda Therapeutics, Inc. (ACOR)

Kerry Clem

A named executive officer of Acorda Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$592,225

Salary $415,000Stock awards $0

FY2021: $662,374

2nd of 4 named executive officers at Acorda Therapeutics by FY2022 total.

4 named officers on file for Acorda Therapeutics, FY2022

Kerry Clem’s pay file — $29

  • 3 fiscal years of pay, line by line
  • ACOR’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Acorda Therapeutics’s whole pay program stands against its peers

  • Acorda Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ACOR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get Kerry Clem’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Kerry Clem compensation by year

Acorda Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Acorda Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$399,800$415,000$415,000
Bonus$0$0$0
Stock awards$0$69,976$0
Option awards$4,999$0$0
Non-equity incentive$190,434$168,698$168,075
Pension and deferred compensation$0$0$0
All other$8,550$8,700$9,150
Total$603,783$662,374$592,225

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Acorda Therapeutics, Inc. DEF 14A filed April 27, 2023, accession 0000950170-23-015404, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Acorda Therapeutics, Inc. filed document, accession 0000950170-23-015404. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$604K
$662K
$592K
FY20
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option111—$81.06
Option1,096—$3.16

Per the Outstanding Equity Awards at Fiscal Year-End table in Acorda Therapeutics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Acorda Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Ron CohenPresident and Chief Executive Officer$984,150
Kerry Clem · this pageChief Commercial Officer$592,225
Lauren SabellaFormer Chief Operating Officer$530,274
Michael GesserChief Finance Officer and Treasurer$459,150

The full Acorda Therapeutics compensation record

free company brief

This page is one person within Acorda Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Acorda Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Acorda Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kerry Clem's compensation dossier · One-time report. No refunds.